These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 15575979)

  • 1. The Janus kinases (Jaks).
    Yamaoka K; Saharinen P; Pesu M; Holt VE; Silvennoinen O; O'Shea JJ
    Genome Biol; 2004; 5(12):253. PubMed ID: 15575979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL12 signaling is independent of Jak2 and Jak3.
    Moriguchi M; Hissong BD; Gadina M; Yamaoka K; Tiffany HL; Murphy PM; Candotti F; O'Shea JJ
    J Biol Chem; 2005 Apr; 280(17):17408-14. PubMed ID: 15611059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Janus Kinase (JAK) FERM and SH2 Domains: Bringing Specificity to JAK-Receptor Interactions.
    Ferrao R; Lupardus PJ
    Front Endocrinol (Lausanne); 2017; 8():71. PubMed ID: 28458652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAKs in pathology: role of Janus kinases in hematopoietic malignancies and immunodeficiencies.
    Vainchenker W; Dusa A; Constantinescu SN
    Semin Cell Dev Biol; 2008 Aug; 19(4):385-93. PubMed ID: 18682296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-regulation of JAK and Src kinases.
    Ingley E; Klinken SP
    Growth Factors; 2006 Mar; 24(1):89-95. PubMed ID: 16393697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK protein kinase inhibitors.
    Thompson JE
    Drug News Perspect; 2005 Jun; 18(5):305-10. PubMed ID: 16193102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling through the hematopoietic cytokine receptors.
    Ihle JN; Witthuhn BA; Quelle FW; Yamamoto K; Silvennoinen O
    Annu Rev Immunol; 1995; 13():369-98. PubMed ID: 7612228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Janus kinase 2 determinants for growth hormone receptor association, surface assembly, and signaling.
    He K; Wang X; Jiang J; Guan R; Bernstein KE; Sayeski PP; Frank SJ
    Mol Endocrinol; 2003 Nov; 17(11):2211-27. PubMed ID: 12920237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A region encompassing the FERM domain of Jak1 is necessary for binding to the cytokine receptor gp130.
    Hilkens CM; Is'harc H; Lillemeier BF; Strobl B; Bates PA; Behrmann I; Kerr IM
    FEBS Lett; 2001 Sep; 505(1):87-91. PubMed ID: 11557047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain.
    Cacalano NA; Migone TS; Bazan F; Hanson EP; Chen M; Candotti F; O'Shea JJ; Johnston JA
    EMBO J; 1999 Mar; 18(6):1549-58. PubMed ID: 10075926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic Insights into Regulation of JAK2 Tyrosine Kinase.
    Hubbard SR
    Front Endocrinol (Lausanne); 2017; 8():361. PubMed ID: 29379470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 - 2012.
    Dymock BW; See CS
    Expert Opin Ther Pat; 2013 Apr; 23(4):449-501. PubMed ID: 23367873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular regulation of Janus kinase (JAK) activation.
    Babon JJ; Lucet IS; Murphy JM; Nicola NA; Varghese LN
    Biochem J; 2014 Aug; 462(1):1-13. PubMed ID: 25057888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol inhibits prolactin-induced activation of the JAK/STAT pathway in cultured astrocytes.
    DeVito WJ; Stone S
    J Cell Biochem; 1999 Aug; 74(2):278-91. PubMed ID: 10404396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells.
    Rane SG; Reddy EP
    Oncogene; 1994 Aug; 9(8):2415-23. PubMed ID: 7518579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Janus kinases in cytokine signalling.
    Ihle JN
    Philos Trans R Soc Lond B Biol Sci; 1996 Feb; 351(1336):159-66. PubMed ID: 8650262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct tyrosine phosphorylation sites in JAK3 kinase domain positively and negatively regulate its enzymatic activity.
    Zhou YJ; Hanson EP; Chen YQ; Magnuson K; Chen M; Swann PG; Wange RL; Changelian PS; O'Shea JJ
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13850-5. PubMed ID: 9391116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jaks and cytokine receptors--an intimate relationship.
    Haan C; Kreis S; Margue C; Behrmann I
    Biochem Pharmacol; 2006 Nov; 72(11):1538-46. PubMed ID: 16750817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus.
    Heim MH
    J Recept Signal Transduct Res; 1999; 19(1-4):75-120. PubMed ID: 10071751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal Epithelial Jak Kinases in Health and Diseases.
    Kumar N; Kuang L; Villa R; Kumar P; Mishra J
    Mediators Inflamm; 2021; 2021():6618924. PubMed ID: 33814980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.